reviewTop 10% cited
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
Leukemia · 2002 · Vol. 16(4) · pp. 508–519
W. Wei‐Lynn Wong✉(Princess Margaret Cancer Centre)Jim Dimitroulakos(Princess Margaret Cancer Centre)MD Minden(University Health Network)Linda Z. Penn(Princess Margaret Cancer Centre)
Cancer, Lipids, and MetabolismLipoproteins and Cardiovascular HealthMetal complexes synthesis and propertiesMevalonate pathwayFarnesyl pyrophosphateStatinGeranylgeranyl pyrophosphateCancer researchApoptosisHMG-CoA reductaseIn vivoPharmacologyMedicine
MeSH terms
Antineoplastic AgentsCell DivisionHumansNeoplasmsApoptosisHydroxymethylglutaryl-CoA Reductase Inhibitors
Citations
574
FWCI
7.80
field-weighted impact
References
166
Percentile
98%
vs. same field & year
Citations per year
References
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Annual Review of Biochemistry · 1999 · 2,764 citations
Induction of Apoptosis by Cancer Chemotherapy
Experimental Cell Research · 2000 · 1,257 citations
The Hallmarks of Cancer
Cell · 2000 · 28,385 citations
Bcl-2 family proteins
Oncogene · 1998 · 1,055 citations
Apoptosis control by death and decoy receptors
Current Opinion in Cell Biology · 1999 · 1,292 citations
BCL-2 family members and the mitochondria in apoptosis
Genes & Development · 1999 · 3,645 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
